🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,444 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9333245

Methods and compositions for treating wounds and reducing the risk of incisional hernias

The Regents of the University of California · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9328391

Cloning and expression of HIV-1 DNA

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9322021

Methods for modulating kallikrein (KLKB1) expression

Ionis Pharmaceuticals, Inc. · Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9322010

Fusion molecule based on novel TAA variant

The Regents of the University of California · Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9315534

Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9315811

Methods for modulating kallikrein (KLKB1) expression

Ionis Pharmaceuticals, Inc. · Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9315813

Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9315467

Compounds for nonsense suppression, and methods for their use

PTC THERAPEUTICS, INC. · Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9303080

Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9297015

Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogen

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9290562

Transferrin-tumstatin fusion protein and methods for producing and using the same

The Regents of the University of Colorado · Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9289468

Fusion protein comprising circularly permuted form of trail/Apo2L, coding gene and use the

Beijing Sunbio Biotech Co. Ltd. · Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9284251

Complex zinc and alpha-chlorocarboxylic acid compounds for treating skin lesions

OBSCHESTVOS S OGRANITCHENNOI OTVETSTVENNOSTJU “OXYGON” · Granted Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9278066

Topical pharmaceutical foam composition

Precision Dermatology, Inc. · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9278161

Tissue-separating fatty acid adhesion barrier

ATRIUM MEDICAL CORPORATION · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9273076

Compounds for nonsense suppression, and methods for their use

PTC THERAPEUTICS, INC. · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9273315

Modulation of huntingtin expression

Ionis Pharmaceuticals, Inc. · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9260726

Targeted integration and expression on exogenous nucleic acid sequences

Sangamo Biosciences, Inc. · Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9260718

Compositions and methods for inhibiting expression of the PCSK9 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9259407

Nanoemulsion therapeutic compositions and methods of using the same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9248113

Infusion and injection solution of Levodopa

Dizlin Medical Design AB · Granted Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9248145

Two alkylresorcinol synthase genes from sorghum; cloning, expression, transformation and c

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9244082

Detection and treatment of LRP4-associated neurotransmission disorders

Georgia Regents Research Institute, Inc. · Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9234196

Compositions and methods for inhibiting expression of transthyretin

Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted